Cosentyx and Dupuytren's contracture - a phase IV clinical study of FDA data

Summary:

Dupuytren's contracture is reported only by a few people who take Cosentyx.

The phase IV clinical study analyzes which people take Cosentyx and have Dupuytren's contracture. It is created by eHealthMe based on reports of 116,009 people who have side effects while taking Cosentyx from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 06, 2022

116,009 people reported to have side effects when taking Cosentyx.
Among them, 4 people (0.0%) have Dupuytren's contracture.


What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 116,171 Cosentyx users for its effectiveness, alternative drugs and more.

What is Dupuytren's contracture?

Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers) is found to be associated with 441 drugs and 203 conditions by eHealthMe.

Number of Cosentyx and Dupuytren's contracture reports submitted per year:

Could Cosentyx cause Dupuytren's contracture?

Gender of people who have Dupuytren's contracture when taking Cosentyx *:

  • female: 0.0 %
  • male: 100 %

Common side effects people have besides Dupuytren's contracture *:

  1. Joint Pain: 4 people, 100.00%
  2. Pelvic Pain: 3 people, 75.00%
  3. Drug Intolerance (drug sensitivity): 3 people, 75.00%
  4. Blood Bilirubin Increased: 3 people, 75.00%
  5. Blood Pressure Systolic Increased: 3 people, 75.00%
  6. Blood Selenium Decreased: 3 people, 75.00%
  7. C-Reactive Protein Increased: 3 people, 75.00%
  8. Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful): 3 people, 75.00%
  9. Dizziness: 3 people, 75.00%
  10. Glycosylated Haemoglobin Increased: 3 people, 75.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cosentyx and have Dupuytren's contracture?

Check whether Dupuytren's contracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Cosentyx:

Dupuytren's contracture treatments and more:

COVID vaccines that are related to Dupuytren's contracture:

How severe was Dupuytren's contracture and when was it recovered:

Expand to all the drugs that have ingredients of secukinumab:

Common drugs associated with Dupuytren's contracture:

All the drugs that are associated with Dupuytren's contracture:

All the conditions that are associated with Dupuytren's contracture:

How the study uses the data?

The study uses data from the FDA. It is based on secukinumab (the active ingredients of Cosentyx) and Cosentyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: